PMDA inspection

AstraZeneca Pharmaceuticals LP

PMDA inspection 5130508039007 · USA · Suitable

Key facts

Control number 5130508039007
Manufacturing site AstraZeneca Pharmaceuticals LP
Location 200 Cardinal Way, Redwood City, California 94063, United States
Country USA
Product type Pharmaceuticals
Application type Regular
Inspection method Remote
Inspection month May 1, 2024
Result Suitable
Result notified May 23, 2024
PMDA registration AG30400581

About PMDA GMP inspections (Japan)

Japan's PMDA conducts GMP and QMS inspections of domestic and foreign manufacturing sites that supply the Japanese market.

Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Browse all PMDA GMP inspections (Japan)